Faculty Information - KOGISO Tomomi

（Last updated : 2025-03-29 13:34:11）

KOGISO Tomomi
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Internal Medicine, Division of Gastroenterology

Position Assistant Professor

■ Published papers

1.	Original article	Impact of ursodeoxycholic acid treatment on Fontan-associated liver disease 2025/02
2.	Original article	Importance of gamma-glutamyl transferase elevation in patients with Fontan-associated liver disease 2024/12
3.	Original article	Epidemiology of Fontan-associated liver disease in Japan: Results from a nationwide survey in 2021 2024/10
4.	Case report	A case of acute liver failure caused by Budd-Chiari syndrome salvaged by brain-dead donor liver transplantation 2024/02
5.	Original article	Serum level of full-length connective tissue growth factor reflects liver fibrosis stage in patients with Fontan-associated liver disease. 2024/01
6.	Review article	Algorithm of ascites management for liver cirrhosis in the tolvaptan era: Paradigm shift treatment improves the outcomes of cirrhotic patients? 2023/09
7.	Original article	Analysis of genetic factors associated with fatty liver disease-related hepatocellular carcinoma 2023/09
8.	Original article	Outcomes of fatty liver disease with and without metabolic comorbidities and risk factors for mortality 2023/05
9.	Original article	The Outcome of Salvage Liver Transplantation and Liver Resection for Recurrent Hepatocellular Carcinoma Using the 5-5-500 Rule, Japanese Extended Liver Transplantation Criteria for Hepatocellular Carcinoma 2023/05
10.	Original article	Cell-free and concentrated ascites reinfusion therapy versus large-volume paracentesis for the treatment of cirrhotic patients with refractory ascites: A multicenter prospective observational study. 2023/03
11.	Original article	Current Therapy and Liver Transplantation for Portopulmonary Hypertension in Japan. 2023/01
12.	Original article	Predictors of liver cirrhosis and hepatocellular carcinoma among perioperative survivors of the Fontan operation. 2023/01
13.	Case report	Giant Hepatic Hemangioma Causing Prolonged Fever and Indicated for Resection. 2022/06
14.	Original article	Portopulmonary hypertension and the risk of high right ventricular systolic pressure in liver transplant candidates. 2022/04
15.	Review article	Transplantation management for living donors 2022/02/23
16.	Original article	Risk factors for Fontan-associated hepatocellular carcinoma. 2022/01
17.	Original article	Prevalence of fatty liver disease after liver transplantation and risk factors for recipients and donors. 2022
18.	Original article	A genome-wide association study identifying SVEP1 variant as a predictor of response to tolvaptan for cirrhotic ascites. 2021/12
19.	Original article	Incidence and Expected Probability of Liver Cirrhosis and Hepatocellular Carcinoma After Fontan Operation. 2021/12
20.	Original article	Risk and protective factors of acute kidney injury in decompensated cirrhotic patients with ascites on tolvaptan. 2021/11
21.	Other	(Guidelines)Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020. 2021/10
22.	Original article	Long-term outcome of Wilson's disease complicated by liver disease. 2021/07
23.	Case report	Long-term Follow-up of a Patient with Portal Hypertension and Hepatic Failure Due to Hepatic Hydatid Disease. 2021/06
24.	Case report	The utility of liver transplantation to treat acute liver failure caused by adult-onset Still's disease: case reports. 2021/06
25.	Original article	Hereditary Apolipoprotein A-1 Amyloidosis With Glu34Lys Mutation Treated by Liver Transplantation: A Case Report. 2021/05
26.	Original article	Development and course of diabetes according to genetic factors and diabetes treatment among patients with nonalcoholic fatty liver disease. 2021/03
27.	Case report	A case of hemorrhage of hepatocellular carcinoma resembling a hepatic cyst arising from non-cirrhotic steatohepatitis. 2021/02
28.	Original article	Eradication of hepatitis C virus with direct-acting antivirals improves glycemic control in diabetes: A multicenter study. 2021/02
29.	Review article	The Current View of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma. 2021/01
30.	Original article	Outcomes of Japanese patients with non-alcoholic fatty liver disease according to genetic background and lifestyle-related diseases. 2021
31.	Original article	Current Status of Portopulmonary Hypertension and Hepatopulmonary Syndrome 2020/12
32.	Original article	Fontan-associated liver disease and hepatocellular carcinoma in adults. 2020/12
33.	Case report	Bardet-Biedl Syndrome Caused by Skipping of SCLT1 Complicated by Microvesicular Steatohepatitis. 2020/11
34.	Original article	Characteristics of NAFLD Based on Hypopituitarism. 2020/10
35.	Original article	Are low triglyceride levels the cause or an outcome of advanced liver fibrosis in elderly patients with nonalcoholic fatty liver disease? 2020/09
36.	Original article	Long-term outcomes of non-alcoholic fatty liver disease and the risk factors for mortality and hepatocellular carcinoma in a Japanese population. 2020/09
37.	Original article	Characteristics of hepatocellular carcinoma arising from Fontan-associated liver disease. 2020/07
38.	Review article	Common Drug Pipelines for the Treatment of Diabetic Nephropathy and Hepatopathy: Can We Kill Two Birds with One Stone? 2020/07
39.	Original article	High Throughput Screening of Serum γ-Glutamyl Dipeptides for Risk Assessment of Nonalcoholic Steatohepatitis with Impaired Glutathione Salvage Pathway. 2020/07
40.	Original article	The characteristics and risk factors of hepatocellular carcinoma in non-alcoholic fatty liver disease without cirrhosis. 2020/05
41.	Case report	Atypical Sarcoidosis Diagnosed by Massive Splenomegaly. 2020/03
42.	Case report	A case of Fontan-related hepatocellular carcinoma successfully treated with proton beam therapy. 2020/02
43.	Original article	Bardet-Biedl Syndrome Caused by Skipping of SCLT1 Complicated by Microvesicular Steatohepatitis. 2020
44.	Original article	Characteristics of acute hepatitis A virus infection before and after 2001: A hospital-based study in Tokyo, Japan. 2019/10
45.	Original article	Characteristics of non-alcoholic steatohepatitis among lean patients in Japan: Not uncommon and not always benign. 2019/08
46.	Case report	An intensive medical care network led to successful living-donor liver transplantation in late-onset hepatic failure with disseminated Staphylococcus aureus infection 2019/04
47.	Original article	Hepatocellular carcinoma after direct-acting antiviral drug treatment in patients with hepatitis C virus. 2019/02
48.	Original article	Characteristics of non-alcoholic steatohepatitis among lean patients in Japan: Not uncommon and not always benign. 2018/12
49.	Case report	Elevated α-Fetoprotein in the Absence of Carcinoma Caused by Relapse of Hepatitis C Viral Infection after Liver Transplantation. 2018/12
50.	Original article	Impact of continued administration of tolvaptan on cirrhotic patients with ascites. 2018/12
51.	Review article	Key roles of hepatologists in successful liver transplantation. 2018/07
52.	Original article	The Outcome of Cirrhotic Patients with Ascites Is Improved by the Normalization of the Serum Sodium Level by Tolvaptan. 2017/11
53.	Original article	Response to tolvaptan and its effect on prognosis in cirrhotic patients with ascites. 2017/08
54.	Original article	Risk factors for recurrence of primary biliary cholangitis after liver transplantation in female patients: A Japanese multicenter retrospective study 2017/07
55.	Case report	Induction of Remission and Maintenance Therapy with Tacrolimus in Refractory Ulcerative Colitis with Adverse Events from 5-ASA and Thiopurine 2017/06
56.	Original article	The Relationship between the Growth Hormone/Insulin-like Growth Factor System and the Histological Features of Nonalcoholic Fatty Liver Disease. 2017/04
57.	Original article	Four cases of type 1 diabetes mellitus showing sharp serum transaminase increases and hepatomegaly due to glycogenic hepatopathy. 2017/03
58.	Original article	IFN-Based and FN-Free Direct-Acting Antivial Drug Treatments for Acquired Hepatitis C Virus in Post-Transplant Recipients 2017
59.	Original article	The Safety of Tolvaptan for Liver Transplantation Candidates and its Impact on Renal Function after Transplantation 2017
60.	Case report	Successful Treatment of Ascites using a Denver Peritoneovenous Shunt in a Patient with Paroxysmal Nocturnal Hemoglobinuria and Budd-Chiari syndrome 2016/10
61.	Original article	Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease : multicenter survey 2016/06
62.	Original article	Safety and efficacy of long-term tolvaptan therapy for decompensated liver cirrhosis 2016/03
63.	Case report	Primary hyperoxaluria complicated with liver cirrhosis:A case report 2015/12
64.	Case report	Spontaneous clearance of HCV accompanying hepatitis after liver transplantation. 2015/10
65.	Case report	Mycophenolate mofetil may induce prolonged severe anemia during pegylated-interferon/ribavirin/simeprevir therapy in liver transplant recipients 2015/06
66.	Original article	Daclatasvir/Asunaprevir therapy provides high tolerability and effectiveness for HCV-positive kidney transplant recipients. 2015
67.	Original article	Efficient Induction of Apoptosis by Week1 Kinase Inhibition in Hepatocellular Carcinoma Cells 2014/06
68.	Original article	Investigation of Ornithine Carbamoyltransferase as a Biomarker of Liver Cirrfosis 2014/06
69.	Original article	Serum metabolomic profile and potential biomarkers for severity of fibrosis in nonalcoholic fatty liver disease 2013/12
70.	Original article	Trancedifferentiation of human fibroblasts into hepatocyte-like cells by defined transcriptional factors 2013/07
71.	Original article	High-sensitivity C-reactive protein as a serum predictor of nonalcoholic fatty liver disease based on the Akaike Information Criterion scoring system in the general Japanese population 2009
Display 5 items
Display all(71)

■ Academic conference presentation

1.	（Young Investigator Workshop APASL_AASLD: HCC/1）Clinical features of MetALD and ALD in patients with hepatocellular carcinoma 2024/03/27
2.	(Symposium31　Diversity in gastroenterology-Gender)Current landscape and future prospects for female gastroentrologists in Japan 2023/11/16
3.	(Panel Discussion1 Steatotic liver disease: Overview)Recent trends in the epidemiology of alcohol-associated liver disease 2023/09/07
4.	Characteristics of fatty liver disease-related hepatocellular carcinoma and genetic background in Japan 2023/04/14
5.	Clinical Features and Risk Factors of Hepatocellular Carcinoma Rising from Alcohol-related Lever Disease 2022/09/01
6.	The Prevalence of Portopulmonary Hypertension and the Clinical Characteristics of the Patients with High Right Ventricular Systolic Pressure in Liver Transplant Candidates 2022/09/01
7.	（Workshop 25: Lifestyle-Related Diseases and HCC）Characteristics of Fatty Liver Disease-related Hepatocellular Carcinoma and Genetic Background in Japan 2022/09/01
8.	（Panel Discussion）Clinical features of non-metabolic associated fatty liver disease in patients with biopsy-proven fatty liver disease 2022/04/20
9.	The characteristics and risk factors of hepatocellular carcinoma in non-alcoholic fatty liver disease without cirrhosis. 2019/11/11
10.	Clinicopathological evaluation of the risk factors for hepatocellular carcinoma arising in patients with alcoholic liver disease 2019/11/08
11.	The characteristics of alcoholic liver disease in Japan 2019/09/21
12.	Characteristics of lean nonalcoholic steatohepatitis/nonalcoholic fatty liver disease by sex in Japan 2019/05/18
13.	Genetic risk for developing cirrosis in japanese patients with alcoholism using genome-wide association study 2019/05/18
14.	The prevalence and Risk of Hepatocellular Carcinoma after Direct-acting AntiViral Drug Treatment in Patients with Hepatitis C Virus 2019/04/18
15.	Characteristics of Liver Tumor Arising from Fontan-Associated Liver Disease 2018/11/09
16.	Genetic Background of Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease Patients 2018/11/09
17.	Eculizumab is effective for Budd-Chiari syndrome with paroxysmal nocturnal hemoglobinuria 2018/10/13
18.	Clinicopathological Evaluation of Hepatocellular Carcinoma Arising in Patients with Nonalcoholic Fatty Liver Disease 2018/06/02
19.	Analysis of biomarkaers predictive of fibrosis progression patients with fontan associated liver 2017/10/20
20.	Immunohistochemical detection of markers for hepatic adenoma in steatohepatitic hepatocellular carcinoma 2017/10/20
21.	The characteristic feature of Japanese ptients with alcoholic liver disease from the view of complicated obesty or sarcopenia 2017/10/20
22.	Effect of conversion to long acting tacrolimus on renal function in long-term-followed patients after liver transplantation 2017/09/24
23.	The characteristic features of japanese lean patients with nonalcoholic steatohepatitis 2017/05/06
24.	Characteristics of Elderly Patients with Nonalcoholic Fatty Liver Disease 2017/04/10
25.	Clinicopathological Characteristics of Steatohepatitic Hepatocellular Carcinoma 2016/11/11
26.	Risk factor of primary biliary cholangitis (PBC) recurrence after liver transplantation in female patients: AJapanese muiticenter retrospective study 2016/11/11
27.	An Efficary and Safety of Daclatasvie/Asunaprevir Therapy for HCV-Postive Kindnet Transplantation 2016/02/20
28.	Characteristic features of microbiomes in alcoholic liver disease analyzed by 16S ribosomal RNA gene pyrosequencing and transcriptional fragment length polymorphism methods using fecal samples: the impact of abstinence 2015/11/13
29.	Risk factors for hepatocellular carcinoma recurrence in patients with nonalcoholic and alcoholic fatty kiver diseases: A Kapanese multicenter survey 2015/11/13
30.	(International Session1 Pathological features of nonalcoholic steatohepatitis(JSH/JSGE))The hostological course of nonalcoholic steatohepatitis:a longitudinal study of sequential liver biopsies 2015/10/08
31.	Resistance to TGF-bera-induced apoptosis is not associated with the de-differenntiation in hepatocellular carcinoma 2015/04/18
32.	Assessment of glycemic variability by continuous glucose monitoring system in patients with nonalcoholic fatty liver disease 2014/11/07
33.	Molecular MechanismsUnderlying the Development of Hepatocellular Carcinoma (HCC) 2014/06/07
34.	Differential expression of cancer stem cell markers and their clinicopathological features in hepatocellular carcinoma patienta with different etiologies 2014/04/09
35.	Clinicopathological features of HCC derived from steatohepatitis 2013/11/01
36.	Serum Metabolomic Profile and Potential Biomarker for Activity and Steatosis in Nonalcoholic Fatty Liver Disease 2013/11/01
37.	The effect of smoking on progress and carcinogenesis in fatty liver disease 2013/11/01
38.	Characteristica of patients with nonalcoholic steratohepatitis and body weight over 100kg 2012/11/02
39.	Hepatic and extrahepatic malignancies in cirrhosis caused by nonalcoholic steatohepatitis and alcoholic liver disease 2012/11/02
40.	Long-term follow up after living donor liver transplantation for autoim-mune liver diseases 2012/02/18
41.	A Case of de novo autoimmune hepatitis follwing liver transplantation for primary biliary cirrhosis 2011/09/25
Display 5 items
Display all(41)

■ Awards & honors

2003/10

AASLD (American Association for the Study of Liver Diseases) : Young Investigator's Travel Award

■ Education

2009/12/18
Degree Acquisition

Tokyo Women's Medical University,